Journal of Biomedical Science and Engineering
Vol.6 No.8B(2013), Paper ID 35767, 8
pages
DOI:10.4236/jbise.2013.68A2004
Stem cell therapy for idiopathic pulmonary fibrosis: How far are we from the bench to the bedside?
Zheng Wang, Xiaoju Zhang, Yi Kang, Yanli Zeng, Hongmei Liu, Xiaoqian Chen, Lijun Ma
Department of Respiratory and Critical Care Medicine, People’s Hospital of Zhengzhou University, Zhengzhou, China
Department of Respiratory and Critical Care Medicine, People’s Hospital of Zhengzhou University, Zhengzhou, China
Department of Infectious Disease, People’s Hospital of Zhengzhou University, Zhengzhou, China
Department of Infectious Disease, People’s Hospital of Zhengzhou University, Zhengzhou, China
Department of Respiratory and Critical Care Medicine, People’s Hospital of Zhengzhou University, Zhengzhou, China
Department of Respiratory Medicine, the Second People’s Hospital of Anhui Province, Hefei, China
Department of Respiratory and Critical Care Medicine, People’s Hospital of Zhengzhou University, Zhengzhou, China
Copyright © 2013 Zheng Wang, Xiaoju Zhang, Yi Kang, Yanli Zeng, Hongmei Liu, Xiaoqian Chen, Lijun Ma et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Wang, Z. , Zhang, X. , Kang, Y. , Zeng, Y. , Liu, H. , Chen, X. and Ma, L. (2013) Stem cell therapy for idiopathic pulmonary fibrosis: How far are we from the bench to the bedside?.
Journal of Biomedical Science and Engineering,
6, 24-31. doi:
10.4236/jbise.2013.68A2004.